/Companies

Faze Medicines

Cambridge, US · Founded 2018 · Delaware corporation · 3 employees on LinkedIn · 2 known investors

Find your way into Faze Medicines

Sign up to see every warm intro you have to Faze Medicines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Faze Medicines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

EF
Ed FreedmanNamed on SEC filing

Board

CPCary Pfeffer
Cary PfefferBoard directorInvestor at Third Rock Ventures
RTRobert Tepper
Robert TepperBoard directorPartner and co-founder of Third Rock Ventures
CHCharles Homcy
Charles HomcyBoard directorInvestor at Third Rock Ventures

Investors · 2

Reported raises · per SEC filings

Form D private placements

$30.4M disclosed across 1 round · 2020

▶$30.4MraisedDec 2020 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cary PfefferExecutive Officer, Director
  • Ed FreedmanExecutive Officer, Director
  • Robert TepperDirector
  • Charles HomcyDirector
Offering amount
$81M
Amount sold
$30.4M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Faze Medicines's investors?
Faze Medicines's investors include Novartis Venture Fund, Third Rock Ventures.
How much funding has Faze Medicines raised?
Faze Medicines has disclosed $30.4M raised across 1 round.
Where is Faze Medicines headquartered?
Faze Medicines is headquartered in Cambridge, US.